Immunological consequences of blood donation.
Marquet
R L
RL
Department of Surgery, Erasmus University, Rotterdam, The Netherlands.
Hoynck van Papendrecht
M A
MA
Busch
O R
OR
Jeekel
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001782:Blood Donors; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D015179:Colorectal Neoplasms / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology